CANF

Can-Fite BioPharma

12 hedge funds and large institutions have $710K invested in Can-Fite BioPharma in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
12
Holders Change
+5
Holders Change %
+71.43%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
2
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
ES
1
Equitec Specialists
Illinois
$265K 118,850 -382,514 -76%
Renaissance Technologies
2
Renaissance Technologies
New York
$190K 85,000 +85,000 New
VKH
3
Virtu KCG Holdings
New York
$112K 50,415 +50,415 New
TAM
4
Taylor Asset Management
Ontario, Canada
$42K 18,900 +18,900 New
MC
5
Menta Capital
California
$27K 12,200 +12,200 New
Goldman Sachs
6
Goldman Sachs
New York
$23K 10,421 +10,421 New
Citadel Advisors
7
Citadel Advisors
Florida
$23K 10,485 +10,485 New
Deutsche Bank
8
Deutsche Bank
Germany
$16K 7,476 -109,524 -94%
UBS Group
9
UBS Group
Switzerland
$5K 2,261 +1,874 +484%
MFS
10
MSI Financial Services
Massachusetts
$4K 2,000 +2,000 New
TRCT
11
Tower Research Capital (TRC)
New York
$2K 696 -804 -54%
Citigroup
12
Citigroup
New York
$1K 487 +44 +10%
Morgan Stanley
13
Morgan Stanley
New York
-1,518 Closed
BRWA
14
B. Riley Wealth Advisors
Florida
-1,000 Closed